
Sign up to save your podcasts
Or


It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
By Mark Ebell4.7
9292 ratings
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.

138 Listeners

694 Listeners

498 Listeners

295 Listeners

300 Listeners

261 Listeners

3,363 Listeners

1,145 Listeners

190 Listeners

95 Listeners

515 Listeners

369 Listeners

247 Listeners

375 Listeners

318 Listeners